• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

包含伊曲康唑、尤特奇和羟丙甲纤维素邻苯二甲酸酯的喷雾干燥三元固体分散体的设计:成分组成的影响

Design of spray dried ternary solid dispersions comprising itraconazole, soluplus and HPMCP: Effect of constituent compositions.

作者信息

Davis Mark T, Potter Catherine B, Mohammadpour Maryam, Albadarin Ahmad B, Walker Gavin M

机构信息

Synthesis and Solid State Pharmaceutical Centre (SSPC), The BernalInstitute, University of Limerick, Ireland.

Synthesis and Solid State Pharmaceutical Centre (SSPC), The BernalInstitute, University of Limerick, Ireland.

出版信息

Int J Pharm. 2017 Mar 15;519(1-2):365-372. doi: 10.1016/j.ijpharm.2017.01.043. Epub 2017 Jan 25.

DOI:10.1016/j.ijpharm.2017.01.043
PMID:28131850
Abstract

A range of 17 ternary formulations of itraconazole (ITZ), HPMCP and Soluplus have been manufactured using spray drying. These amorphous solid dispersions (ASDs) were very stable against crystallisation and ITZ was found to be amorphous in all formulations after one year at 40°C/75% RH. A number of solid state analytical techniques including PXRD, DSC, small angle X-ray scattering, FTIR and solid state NMR were used to characterise the physicochemical properties of the ASDs following processing and storage and to assess any interactions between components. Microtrac laser scattering analysis revealed a relationship between polymer levels and particle size distribution (PSD). Dissolution studies indicated that higher Soluplus content in the formulation resulted in higher concentrations of ITZ in acidic media.

摘要

已通过喷雾干燥制备了一系列包含伊曲康唑(ITZ)、羟丙甲纤维素邻苯二甲酸酯(HPMCP)和聚乙烯己内酰胺(Soluplus)的17种三元制剂。这些无定形固体分散体(ASD)对结晶非常稳定,并且在40°C/75%相对湿度下放置一年后,发现所有制剂中的ITZ均为无定形。使用了多种固态分析技术,包括粉末X射线衍射(PXRD)、差示扫描量热法(DSC)、小角X射线散射、傅里叶变换红外光谱(FTIR)和固态核磁共振,来表征加工和储存后ASD的物理化学性质,并评估各组分之间的任何相互作用。Microtrac激光散射分析揭示了聚合物含量与粒度分布(PSD)之间的关系。溶出度研究表明,制剂中较高的Soluplus含量会导致在酸性介质中ITZ的浓度更高。

相似文献

1
Design of spray dried ternary solid dispersions comprising itraconazole, soluplus and HPMCP: Effect of constituent compositions.包含伊曲康唑、尤特奇和羟丙甲纤维素邻苯二甲酸酯的喷雾干燥三元固体分散体的设计:成分组成的影响
Int J Pharm. 2017 Mar 15;519(1-2):365-372. doi: 10.1016/j.ijpharm.2017.01.043. Epub 2017 Jan 25.
2
Development of stability-enhanced ternary solid dispersions via combinations of HPMCP and Soluplus processed by hot melt extrusion.通过热熔挤出法制备的HPMCP与固体分散体组合开发稳定性增强的三元固体分散体。
Int J Pharm. 2017 Oct 30;532(1):603-611. doi: 10.1016/j.ijpharm.2017.09.035. Epub 2017 Sep 18.
3
Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension.与伊曲康唑纳米混悬剂相比,伊曲康唑/Soluplus 挤出物的溶解和口服吸收增加。
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):1285-92. doi: 10.1016/j.ejpb.2013.03.002. Epub 2013 Apr 3.
4
Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties.吸入用伊曲康唑固体分散体,具有增强的溶解、溶解和分散性能。
Int J Pharm. 2012 May 30;428(1-2):103-13. doi: 10.1016/j.ijpharm.2012.03.002. Epub 2012 Mar 10.
5
Spray drying ternary amorphous solid dispersions of ibuprofen - An investigation into critical formulation and processing parameters.喷雾干燥布洛芬三元无定形固体分散体:关键配方和工艺参数研究。
Eur J Pharm Biopharm. 2017 Nov;120:43-51. doi: 10.1016/j.ejpb.2017.08.005. Epub 2017 Aug 16.
6
Effect of Compression on the Molecular Arrangement of Itraconazole-Soluplus Solid Dispersions: Induction of Liquid Crystals or Exacerbation of Phase Separation?压缩对伊曲康唑 - 固体分散体分子排列的影响:诱导液晶形成还是加剧相分离?
Mol Pharm. 2016 Jun 6;13(6):1879-93. doi: 10.1021/acs.molpharmaceut.6b00046. Epub 2016 May 4.
7
Continuous production of itraconazole-based solid dispersions by hot melt extrusion: Preformulation, optimization and design space determination.通过热熔挤出法连续生产基于伊曲康唑的固体分散体:处方前研究、优化及设计空间确定
Int J Pharm. 2016 Dec 30;515(1-2):114-124. doi: 10.1016/j.ijpharm.2016.10.003. Epub 2016 Oct 5.
8
Application of film-casting technique to investigate drug-polymer miscibility in solid dispersion and hot-melt extrudate.应用流延成型技术研究药物与聚合物在固体分散体和热熔挤出物中的混溶性。
J Pharm Sci. 2015 Jul;104(7):2142-52. doi: 10.1002/jps.24446. Epub 2015 Apr 27.
9
Determination of drug-polymer solubility from supersaturated spray-dried amorphous solid dispersions: A case study with Efavirenz and Soluplus®.从过饱和喷雾干燥无定形固体分散体中测定药物-聚合物溶解度:以依非韦伦和Soluplus®为例。
Eur J Pharm Biopharm. 2019 Sep;142:300-306. doi: 10.1016/j.ejpb.2019.06.028. Epub 2019 Jun 24.
10
Enhanced pulmonary absorption of poorly soluble itraconazole by micronized cocrystal dry powder formulations.通过微粉化共晶干粉制剂增强难溶性伊曲康唑的肺部吸收。
Eur J Pharm Biopharm. 2017 Jun;115:65-72. doi: 10.1016/j.ejpb.2017.02.013. Epub 2017 Feb 20.

引用本文的文献

1
Mechanochemical Approach to Obtaining a Multicomponent Fisetin Delivery System Improving Its Solubility and Biological Activity.机械化学法制备多组分非瑟酮给药系统以提高其溶解度和生物活性。
Int J Mol Sci. 2024 Mar 25;25(7):3648. doi: 10.3390/ijms25073648.
2
Amorphous Solid Dispersion as Drug Delivery Vehicles in Cancer.无定形固体分散体作为癌症治疗中的药物递送载体
Polymers (Basel). 2023 Aug 11;15(16):3380. doi: 10.3390/polym15163380.
3
Ternary Solid Dispersions: A Review of the Preparation, Characterization, Mechanism of Drug Release, and Physical Stability.
三元固体分散体:制备、表征、药物释放机制及物理稳定性综述
Pharmaceutics. 2023 Aug 10;15(8):2116. doi: 10.3390/pharmaceutics15082116.
4
Release Enhancement by Plasticizer Inclusion for Amorphous Solid Dispersions Containing High T Drugs.增塑剂包合提高高 Tg 药物无定形固体分散体的释放度。
Pharm Res. 2023 Mar;40(3):777-790. doi: 10.1007/s11095-023-03483-3. Epub 2023 Mar 1.
5
Cyclosporine A-Loaded Ternary Solid Dispersion Prepared with Fine Droplet Drying Process for Improvement of Storage Stability and Oral Bioavailability.采用微滴干燥法制备的载环孢素A三元固体分散体,用于提高储存稳定性和口服生物利用度。
Pharmaceutics. 2023 Feb 8;15(2):571. doi: 10.3390/pharmaceutics15020571.
6
Impact of Gastric pH Variations on the Release of Amorphous Solid Dispersion Formulations Containing a Weakly Basic Drug and Enteric Polymers.胃内 pH 值变化对含有弱碱性药物和肠溶性聚合物的无定形固体分散体制剂释放的影响。
Mol Pharm. 2023 Mar 6;20(3):1681-1695. doi: 10.1021/acs.molpharmaceut.2c00895. Epub 2023 Feb 2.
7
Improved Bioavailability of Poorly Water-Soluble Drug by Targeting Increased Absorption through Solubility Enhancement and Precipitation Inhibition.通过增强溶解度和抑制沉淀靶向提高吸收来改善难溶性药物的生物利用度
Pharmaceuticals (Basel). 2021 Dec 2;14(12):1255. doi: 10.3390/ph14121255.
8
Amorphous Solid Dispersions (ASDs): The Influence of Material Properties, Manufacturing Processes and Analytical Technologies in Drug Product Development.无定形固体分散体(ASDs):材料特性、制造工艺及分析技术在药物产品开发中的影响
Pharmaceutics. 2021 Oct 14;13(10):1682. doi: 10.3390/pharmaceutics13101682.
9
Insoluble Polymers in Solid Dispersions for Improving Bioavailability of Poorly Water-Soluble Drugs.用于提高难溶性药物生物利用度的固体分散体中的不溶性聚合物
Polymers (Basel). 2020 Jul 28;12(8):1679. doi: 10.3390/polym12081679.
10
Nepafenac-Loaded Cyclodextrin/Polymer Nanoaggregates: A New Approach to Eye Drop Formulation.载萘帕芬酸的环糊精/聚合物纳米聚集体:滴眼剂配方的新方法
Materials (Basel). 2019 Jan 11;12(2):229. doi: 10.3390/ma12020229.